A robust education and treatment plan are key to helping those who suffer from one of the most common pregnancy complications.
The EncircleRxSM portfolio is part of our GLP-1 Management Suite of Solutions that helps plan sponsors reduce costs and enhance outcomes. EncircleRx: Cardiodiabesity gives clients optionality and predictability in managing cardiodiabesity—obesity, diabetes and cardiovascular disease—with the first-ever GLP-1 financial guarantee from a PBM.
Obesity, diabetes, and cardiovascular disease are on the rise. Left unmanaged, these comorbid conditions can cause medical expenses to skyrocket and lead to poor health outcomes, inclusive of disability, and death.
Our study, which is based on 495,180 adults with diagnosed ADHD, uncovered that social and economic factors impact the prevalence of ADHD treatment.
We believe robust pharmacy networks are critical to ensuring access for Medicare customers and that individual pharmacists deserve the opportunity to make the decision that’s best for their business.
Accelerating access to innovative therapies by connecting patients to clinical research. Our data-driven approach helps sponsors recruit faster, engage diverse populations and improve outcomes across the healthcare ecosystem.
Losing a pregnancy can have traumatic psychological impacts on women. When left untreated, they can have detrimental and long-lasting effects on the health and well-being of these women and their families.
Among the key takeaways from the AHIP 2023 conference: The health care system must do a better job of working together to provide people with the right behavioral health care resources at the right time, with measurable outcomes.
A behind-the-scenes look at how Express Scripts Pharmacy by Evernorth gets medication from our door to yours.